Treatment of multiple sclerosis: recent trials and future perspectives
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Clinical Neurology,Neurology
Reference122 articles.
1. Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
2. Interferons in the Treatment of Multiple Sclerosis
3. Interferons Should Be Used to Treat Most Patients With MS
4. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Association between CD24 Ala/Val polymorphism and multiple sclerosis risk;Medicine;2020-04
2. Pathophysiologisch ansetzende Therapie;Multiple Sklerose;2015
3. Efficacy of combination therapy with erythropoietin and methylprednisolone in clinical recovery of severe relapse in multiple sclerosis;Acta Neurologica Belgica;2014-03-07
4. Nuevos fármacos para el tratamiento de la esclerosis múltiple;FMC - Formación Médica Continuada en Atención Primaria;2011-11
5. Investigation of CD24 and Its Expression in Iranian Relapsing-Remitting Multiple Sclerosis;International Journal of Neuroscience;2011-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3